Carrier Screening Global Market Report 2023 – By T Carrier Screening Global Market Report 2023 – By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), By Product and Service (Service, Product), By Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Carrier screening refers to a type of genetic test that can determine if there is a gene that causes certain genetic illnesses. The carrier screening is used to identify people who have one copy of a gene mutation that produces a hereditary illness when two copies are present. For further insights on the carrier screening market, request a sample here

The carrier screening market growth is aided by an increase in fetal chromosomal abnormalities and genetic disorders. For further insights on the carrier screening market, request a sample here

The carrier screening market is expected to reach $4.30 billion in 2027 at a rate of 15.9%. For further insights on the carrier screening market, request a sample here

The global carrier screening market is segmented as
1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening
2) By Product and Service: Service, Product
3) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions
4) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies
5) By End User: Hospitals, Reference Laboratories, Physician Offices and Clinics, Other End Users
For further insights on the carrier screening market, request a sample here

North America was the largest region in the carrier screening market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the carrier screening market are, Invitae Corporation, Fulgent Genetics Inc., Illumina Inc., Sema4 Holdings Corporation, Natera Inc., Laboratory Corporation of America Holdings, Centogene NV, Thermo Fisher Scientific Inc., Myriad Genetics Inc., Eurofins Scientific SE, OPKO Health Inc., Quest Diagnostics Inc., Luminex Corporation, BGI Genomics, Gene by Gene, OME Care, MedGenome Inc., Otogenetics Corporation. For further insights on the carrier screening market, request a sample here.

Major trends influencing the carrier screening market include technological advancements. Major companies operating in the carrier screening market are focused on developing new technological solutions to strengthen their position. For further insights on the carrier screening market, request a sample here.

For detailed insights on the major opportunities and strategies in the carrier screening market, request a sample here.

For detailed insights on carrier screening market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the carrier screening industry, request a sample here.

For detailed insights on the key dynamics influencing the carrier screening market growth and SWOT analysis of the carrier screening industry, request a sample here.